East Tennessee State University

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, East Tennessee State University sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials 1 currently recruiting 13 completed later-stage tilt top decile by trial count

East Tennessee State University: 16 sponsored US clinical trials, 1 recruiting.

East Tennessee State University sponsors 16 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Restless Legs Syndrome, with 1 trials.

Top-decile sponsor footprint

East Tennessee State University ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 72/100

13 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

16 total, page 1 of 1

RECRUITING NA

Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease

NCT07551661

NOT YET RECRUITING NA

Contingency Management to Reinforce Attendance to Cognitive Behavioral Treatment for Gambling Disorder

NCT07016100

COMPLETED NA

Reducing Stigma Among Individuals With Addiction and Staff in the Criminal Justice System

NCT05152342

COMPLETED NA

Treatment for Teachers With Vocal Fatigue

NCT04486989

COMPLETED

Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes

NCT03435198

TERMINATED NA

Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

NCT03067480

COMPLETED NA

Feasibility of a Tablet-based Fall Prevention Program for Older Adults

NCT02949986

COMPLETED

Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic

NCT02187796

COMPLETED NA

An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk

NCT01508013

COMPLETED NA

Primary Care Child Obesity Intervention Targeting Parents

NCT01729910

COMPLETED Phase 2

Bupropion and Restless Legs Syndrome

NCT00621517

COMPLETED Phase 4

Quetiapine Compared With Placebo in the Management of Fibromyalgia

NCT01458964

COMPLETED NA

Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome

NCT00727779

COMPLETED Phase 4

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

NCT01799850

COMPLETED NA

Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease

NCT04195932

COMPLETED NA

Exercise as an Modulator of Immunological Risk Factors for Osteoporosis

NCT02765945

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 2

Where East Tennessee State University enrollment is open (later-stage tilt)

1 recruiting of 16 indexed (6% open); 13 completed (81%).

Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Restless Legs Syndrome (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

East Tennessee State University: open-pipeline peers nationwide

Peers matched on 16 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

East Tennessee State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1020304050 0%5%10%15% Total trials Recruiting share East Tennessee State UniversityAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera PharmaceuticalsAlbert Einstein Healthcare NetworkBassett HealthcareDynavax Technologies CorporationMonell Chemical Senses Center
East Tennessee State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

East Tennessee State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

What to do with this East Tennessee State University page

16 registered trials is a research-attention snapshot, not an endorsement of East Tennessee State University or any single study.

  • 1 of East Tennessee State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Restless Legs Syndrome is the condition East Tennessee State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Restless Legs Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

East Tennessee State University pipeline card: 16 registered trials from official public datasets.Report a data error.